Press Releases

Jim Flatt CEO DMC Biotechnologies Headshot_sqr

Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies

MORRISVILLE, NC – January 14, 2025 – DMC Biotechnologies, a leader in synthetic biology and precision fermentation, is pleased to announce the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings more than 30 years...
DMC’s Downstream Processing Proven At Scale

DMC’s Downstream Processing Proven At Scale

13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstration of…

read more